Dmitry Zamansky, serving as the Chief Product and Technology Officer for American Well Corp (NASDAQ: AMWL), executed a transaction involving the sale of 8,460 shares of Class A Common Stock on July 1, 2026. The aggregate value of this divestment reached $78,931, with each share transacted at a price point of $9.33. This sale activity occurred against a backdrop of significant price appreciation for the telehealth company, with the stock recording an 86% increase over the preceding six months and trading in close proximity to its 52-week peak of $9.96.
Regulatory filings indicate that this disposal of shares was not a discretionary market move by Mr. Zamansky. Instead, the transaction was structured specifically to cover tax liabilities generated from the vesting and settlement of restricted stock units on the identical date. Following the completion of this automatic sell-to-cover mechanism, Mr. Zamansky retained a direct ownership position of 232,620 shares of American Well Corp Class A Common Stock.
Concurrent with executive share activity, American Well is undergoing a notable leadership shift. Dr. Roy Schoenberg, a co-founder of the organization, has resigned from the board of directors. The resignation stems from a new employment opportunity unrelated to any internal disagreements with the company. In a related development, Amazon has announced that Dr. Schoenberg will assume a leadership position within its healthcare business division, effective July 1.
Financially, the telehealth provider reported its first-quarter 2026 results, revealing a total revenue figure of $54.9 million. This figure represents an 18% decline compared to the previous year. Despite the contraction in top-line revenue, the company highlighted a 43% improvement in its operating loss, signaling progress toward profitability objectives. Truist Securities has maintained a Hold rating on AMWL shares, setting a price target of $7.50.
Operational developments also include the performance of SilverCloud, Amwell's digital mental health platform. A study funded by the National Institute of Mental Health, conducted across 26 U.S. colleges and universities with 6,205 students, demonstrated positive results. The research highlighted the platform's effectiveness in supporting individuals at high risk for anxiety, depression, or eating disorders.
Valuation assessments from InvestingPro suggest that AMWL appears undervalued based on fair value metrics. Investors seeking deeper analysis can access additional financial tips and comprehensive metrics to evaluate the company's prospects. The combination of executive transitions, financial adjustments, and clinical validation of digital health tools defines the current landscape for American Well.